Patent details

Basic Information

Publication number:

EP2405748

PCT Application Number:

US2010027096

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107514614

PCT Publication Number:

WO2010105129

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ADMINISTRATION OF INTRAVENOUS IBUPROFEN

French Title of Invention:

ADMINISTRATION D'IBUPROFÈNE PAR VOIE INTRAVEINEUSE

German Title of Invention:

VERABREICHUNG VON INTRAVENÖSEM IBUPROFEN

SPC Number:

Dates

Filing date:

12/03/2010

Grant date:

15/08/2018

EP Publication Date:

18/01/2012

PCT Publication Date:

16/09/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/08/2018

EP B1 Publication Date:

15/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/03/2019

Expiration date:

12/03/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/08/2018

 

 

Name:

Cumberland Pharmaceuticals Inc.

Address:

2525 West End Avenue Suite 950, Nashville, TN 37203, United States (US)

Inventor

Name:

PAVLIV, Leo

Address:

United States (US)

Priority

Priority Number:

159585 P

Priority Date:

12/03/2009

Priority Country:

United States (US)

Classification

IPC classification:

A01N 37/10; A61K 9/00; A61K 9/08; A61K 31/19; A61K 31/192; A61K 31/485; A61P 41/00;

Publication

European Patent Bulletin

1

Issue number:

201833

Publication date:

15/08/2018

Description:

Grant (B1)

2

Issue number:

201834

Publication date:

22/08/2018

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages